Acrivon Therapeutics
ACRV
#8407
Rank
โ‚น15.02 B
Marketcap
โ‚น461.82
Share price
-4.51%
Change (1 day)
12.74%
Change (1 year)

Acrivon Therapeutics (ACRV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น1.55 Billion

According to Acrivon Therapeutics's latest financial reports the company's total liabilities are โ‚น1.55 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Acrivon Therapeutics - Total liabilities on balance sheet (from 2021 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น1.42 B59.73%
2022-12-31โ‚น0.88 B-90.83%
2021-12-31โ‚น9.70 B1152.21%
2020-12-31โ‚น0.77 B